Close Menu

NEW YORK (GenomeWeb) – Natera and Belgian cancer reference center Institut Jules Bordet plan to collaborate on a breast cancer research project using Natera's circulating tumor DNA assay, Signatera.

Natera will analyze around 300 plasma samples prospectively collected from 80 patients diagnosed with non-metastatic breast cancer who were all treated with chemotherapy followed by surgery.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.